Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs recombinant FSH and/or HP-hMG for controlled ovarian stimulation in oocyte donors
2014-001743-20Phase 4Active
- Sponsor
- International Vaccine Institute
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of corifollitropin alfa in superovulation (3 arms), sponsored by International Vaccine Institute. Started Aug 2014; status: active.
02
Drugs
corifollitropin alfa
03
Conditions
superovulation
Beyond the preview
Go deeper on 2014-001743-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001743-20.